首页> 外文期刊>Proceedings of the National Academy of Sciences of the United States of America >Combinations of biomarkers predictive of later life mortality
【24h】

Combinations of biomarkers predictive of later life mortality

机译:结合生物标志物预测晚年死亡率

获取原文
获取原文并翻译 | 示例
       

摘要

A wide range of biomarkers, reflecting activity in a number of biological systems (e.g., neuroendocrine, immune, cardiovascular, and metabolic), have been found to prospectively predict disability, morbidity, and mortality outcomes in older adult populations. Levels of these biomarkers, singly or in combination, may serve as an early warning system of risk for future adverse health outcomes. In the current investigation, 13 biomarkers were examined as predictors of mortality occurrence over a 12-year period in a sample of men and women (n = 1,189) 70-79 years of age at enrollment into the study. Biomarkers examined in analyses included markers of neuroendocrine functioning (epinephrine, norepinephrine, cortisol, and dehydroepiandrosterone), immune activity (C-reactive protein, fibrinogen, IL-6, and albumin), cardiovascular functioning (systolic and diastolic blood pressure), and metabolic activity [high-density lipoprotein (HDL) cholesterol, total to HDL cholesterol ratio, and glycosylated hemoglobin]. Recursive partitioning techniques were used to identify a set of pathways, composed of combinations of different biomarkers, that were associated with a high-risk of mortality over the 12-year period. Of the 13 biomarkers examined, almost all entered into one or more high-risk pathways although combinations of neuroendocrine and immune markers appeared frequently in high-risk male pathways, and systolic blood pressure was present in combination with other biomarkers in all high-risk female pathways. These findings illustrate the utility of recursive partitioning techniques in identifying biomarker combinations predictive of mortal outcomes in older adults, as well as the multiplicity of biological pathways to mortality in elderly populations.
机译:已经发现反映了许多生物系统(例如,神经内分泌,免疫,心血管和代谢)活动的多种生物标志物可预期地预测老年人群的残疾,发病率和死亡率。这些生物标志物的水平(单独或组合使用)可作为未来不良健康后果风险的预警系统。在当前的调查中,入选该研究的70-79岁年龄段的男性和女性(n = 1189)(年龄= 1189)中,检查了13种生物标记物作为12年内死亡率的预测指标。分析中检查的生物标志物包括神经内分泌功能(肾上腺素,去甲肾上腺素,皮质醇和脱氢表雄酮),免疫活性(C反应蛋白,纤维蛋白原,IL-6和白蛋白),心血管功能(收缩压和舒张压)和代谢物的标志物活性[高密度脂蛋白(HDL)胆固醇,总胆固醇与HDL胆固醇之比和糖基化血红蛋白]。递归划分技术用于识别由不同生物标志物的组合组成的一组途径,这些途径与12年期间的高死亡风险相关。在所检查的13种生物标志物中,尽管神经内分泌和免疫标志物的组合在高危男性途径中频繁出现,并且几乎所有高危女性中都存在收缩压与其他生物标志物的结合,但几乎所有生物标志物都进入了一种或多种高危途径。途径。这些发现说明了递归分割技术在识别可预测老年人死亡结果的生物标志物组合以及老年人群死亡率的多种生物途径方面的实用性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号